NCT05640375View on ClinicalTrials.gov

Follow-up and Steroid Treatment Results in Intussusception

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

December 24, 2019

Primary Completion Date

December 24, 2023

Study Completion Date

December 24, 2023

Conditions
Intussusception
Interventions
DRUG

Methylprednisolone

Single dose, 1 mg/kg

Trial Locations (1)

06490

Baskent University, Ankara

All Listed Sponsors
lead

Baskent University

OTHER

NCT05640375 - Follow-up and Steroid Treatment Results in Intussusception | Biotech Hunter | Biotech Hunter